How should the DRNA historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?
There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Dicerna Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this DRNA Historical PE Ratio page.
What is the average historical PE for DRNA based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?
The DRNA historical PE ratio using the annualized quarterly earnings method works out to NA.
What is the average historical PE for DRNA based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?
The DRNA historical PE ratio using the TTM earnings method works out to NA.
On this page we presented the DRNA Historical PE Ratio
information for Dicerna Pharmaceuticals' stock.
The average DRNA historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average DRNA historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.
Let's now compare this DRNA historical PE result, against the recent PE: when this page was posted on 11/10/2021, the most recent closing price for DRNA had been 21.80, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.
For self directed investors doing their due diligence on DRNA or any other given stock, valuation analysis for DRNA
can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis
as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.
That's why we bring you HistoricalPERatio
.com to make it easy for investors to investigate
Dicerna Pharmaceuticals PE history or the past PE information for any stock in our coverage universe.
And in your continued research we hope you will be sure to check out the further links included for earnings
surprises history (beat/miss data) as well as next earnings dates for DRNA. Thanks for visiting, and the next
time you need to research DRNA Historical PE Ratio
or the ratio for another stock, we hope you'll think of our site, as your
go-to historical PE ratio research resource of choice.